Zimmer Biomet To Settle Overseas Bribery Charges With US DOJ

The orthopedic device company is set to pay $17.4m to the US Department of Justice and an additional $13m to the Securities and Exchange Commission to resolve allegations that Biomet didn’t stop corrupt acts in Brazil and Mexico even after a 2012 deferred prosecution agreement.

More from Legal & IP

More from Policy & Regulation